Impel Pharmaceuticals Inc.

IMPL · NASDAQ
Analyze with AI
9/30/2023
6/30/2023
3/31/2023
12/31/2022
Assets
Cash & Equivalents$239$15,162$35,465$60,654
Short-Term Investments$0$0$0$0
Receivables$6,592$6,814$6,280$7,444
Inventory$6,864$6,985$8,014$8,427
Other Curr. Assets$9,732$3,943$2,125$3,284
Total Curr. Assets$23,427$32,904$51,884$79,809
Property Plant & Equip (Net)$7,817$8,386$8,914$6,995
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$3,829$3,517$3,931$1,746
Total NC Assets$11,646$11,903$12,845$8,741
Other Assets$0$0$0$0
Total Assets$35,073$44,807$64,729$88,550
Liabilities
Payables$3,734$3,458$6,133$6,092
Short-Term Debt$112,563$49,551$1,736$1,541
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$8,446$68,212$14,413$14,530
Total Curr. Liab.$124,743$121,221$22,282$22,163
LT Debt$2,235$2,744$51,169$49,645
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$64,183$60,899
Total NC Liab.$2,235$2,744$115,352$110,544
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$126,978$123,965$137,634$132,707
Equity
Pref Stock$0$0$0$0
Common Stock$24$24$24$24
Retained Earnings-$372,348-$358,534-$351,177-$321,110
AOCI$0$0$0$0
Other Equity$280,419$279,352$278,248$276,929
Total Equity-$91,905-$79,158-$72,905-$44,157
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$35,073$44,807$64,729$88,550
Net Debt$114,559$37,133$17,440-$9,468